1. Home
  2. BK vs BSX Comparison

BK vs BSX Comparison

Compare BK & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Bank of New York Mellon Corporation

BK

The Bank of New York Mellon Corporation

HOLD

Current Price

$137.43

Market Cap

78.9B

Sector

Finance

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$47.84

Market Cap

93.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BK
BSX
Founded
1784
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.9B
93.4B
IPO Year
2013
2010

Fundamental Metrics

Financial Performance
Metric
BK
BSX
Price
$137.43
$47.84
Analyst Decision
Buy
Strong Buy
Analyst Count
13
22
Target Price
$134.42
$93.18
AVG Volume (30 Days)
3.0M
21.0M
Earning Date
04-16-2026
04-22-2026
Dividend Yield
1.60%
N/A
EPS Growth
27.59
55.20
EPS
2.24
0.90
Revenue
$20,080,000,000.00
$9,076,000,000.00
Revenue This Year
$9.23
$11.85
Revenue Next Year
$4.53
$10.16
P/E Ratio
$61.23
$53.70
Revenue Growth
7.85
12.49
52 Week Low
$88.19
$47.17
52 Week High
$139.15
$109.50

Technical Indicators

Market Signals
Indicator
BK
BSX
Relative Strength Index (RSI) 65.20 30.55
Support Level $130.53 $47.17
Resistance Level $139.15 $58.35
Average True Range (ATR) 2.69 1.46
MACD -0.02 0.05
Stochastic Oscillator 82.69 8.19

Price Performance

Historical Comparison
BK
BSX

About BK The Bank of New York Mellon Corporation

Bank of New York Mellon is a global investment company involved in managing and servicing financial assets throughout the investment lifecycle. The bank provides financial services for institutions, corporations, and individual investors, delivering investment management and services in 35 countries and more than 100 markets. BNY is the largest global custody bank in the world, with $59.3 trillion in under custody or administration (as of December 2025), and can act as a single point of contact for clients looking to create, trade, hold, manage, service, distribute, or restructure investments. BNY's asset-management division manages about $2.2 trillion in assets.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: